Evidence map›Paper›PMID 35207355›Full record

ReviewJournal of clinical medicine2022

Pancreatic Stone Protein: Review of a New Biomarker in Sepsis.

Pedro Fidalgo, David Nora, Luis Coelho, Pedro Povoa

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Review
  7. Be-SNAP: the Belgian Sepsis National Action Plan.Frontiers in public health · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Pedro FidalgoPolyvalent Intensive Care Unit, Hospital São Francisco Xavier, CHLO, 1449-005 Lisbon, Portugal.ORCID 0000-0001-8835-0969
David NoraPolyvalent Intensive Care Unit, Hospital São Francisco Xavier, CHLO, 1449-005 Lisbon, Portugal.ORCID 0000-0002-1133-7368
Luis CoelhoPolyvalent Intensive Care Unit, Hospital São Francisco Xavier, CHLO, 1449-005 Lisbon, Portugal.ORCID 0000-0003-0701-3624
Pedro PovoaPolyvalent Intensive Care Unit, Hospital São Francisco Xavier, CHLO, 1449-005 Lisbon, Portugal.
University of Lisbon · PTHospital of St. Francis Xavier · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sepsis is a life-threatening syndrome characterized by a dysregulated host response to an infection that may evolve rapidly into septic shock and multiple organ failure. Management of sepsis relies on the early recognition and diagnosis of infection and the providing of adequate and prompt antibiotic therapy and organ support. A novel protein biomarker, the pancreatic stone protein (PSP), has recently been studied as a biomarker of sepsis and the available evidence suggests that it has a higher diagnostic performance for the identification of infection than the most used available biomarkers and adds prognostic value. This review summarizes the clinical evidence available for PSP in the diagnosis and prognosis of sepsis.

Indexed as

biomarkerinfectionpancreatic stone proteinsepsis

Identifiers

PMID35207355
PMCPMC8880320
OpenAlexW4214487497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.